Influence of HLADQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring: A Retrospective Cohort Study.
Esteban Fuentes-ValenzuelaFrancisco Javier García-AlonsoCarlos Maroto-MartínLaura Juan CasamayorJosé Antonio GarroteRosendo Almendros MuñozÁngel De PradoAlejando Vara CastrodezaMaría Ángeles MarineroRaquel Calleja CarbajosaJesús BarrioPublished in: Inflammatory bowel diseases (2023)
In adult patients with PTDM, a positive HLA-DQA1*05 genotype does not associate a higher risk of treatment cessation nor worse clinical outcomes.
Keyphrases